Antibody: | Nonec | anti-CD4c | anti-VSV Gc |
---|
Particleb | Env+ | Env- | Env+ | Env- | Env+ | Env- |
HIV-1-Neo(w/o CD4) | 3 | 4 | 4 | 0 | 3 | 4 |
HIV-1-Neo(CD4) | 403 | 5 | 6 | 3 | 401 | 3 |
HIV-1-Neo(CD4/gpi) | 363 | 2 | 7 | 3 | 391 | 4 |
HIV-1-Neo(G) | 591 | 517 | 446 | 550 | 4 | 6 |
- a105 Env+ TF228 or 105 Env- BJAB cells were infected and neomycin-resistant cell colonies were selected in soft agar and counted after two weeks. The average number of selected colonies is presented from at least two titrations.
- b Vector particles were collected from human 293 cell supernatants after single DNA transfection with HIV-1-Neo or after cotransfection of HIV-1-Neo DNAs with DNAs encoding either CD4, CD4/gpi or the glycoprotein G of vesicular stomatitis virus, respectively.
- c1 ng p24 of each vector type was preincubated for 30 min with or without 2 mg/ml antibody directed either against the CD4 ectodomain or the vesicular stomatitis virus glycoprotein G prior to infections.